MarketBeat Instant News Alerts 2 hours agoCemex (NYSE:CX) Given "Hold (C)" Rating at Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c)" rating on shares of Cemex in a research report on Friday.NYSE:CXRead Cemex (NYSE:CX) Given "Hold (C)" Rating at Weiss Ratings2 hours agoCementos Pacasmayo S.A.A.'s (CPAC) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c)" rating on shares of Cementos Pacasmayo S.A.A. in a report on Friday.NYSE:CPACRead Cementos Pacasmayo S.A.A.'s (CPAC) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoCelularity (NASDAQ:CELU) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Celularity in a research report on Friday.NASDAQ:CELURead Celularity (NASDAQ:CELU) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoCellectis (NASDAQ:CLLS) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d-)" rating on shares of Cellectis in a report on Friday.NASDAQ:CLLSRead Cellectis (NASDAQ:CLLS) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoCellebrite DI's (CLBT) "Sell (D+)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d+)" rating on shares of Cellebrite DI in a report on Friday.NASDAQ:CLBTRead Cellebrite DI's (CLBT) "Sell (D+)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Celldex Therapeutics (NASDAQ:CLDX)MarketBeatWeiss Ratings reissued a "sell (d-)" rating on shares of Celldex Therapeutics in a research report on Friday.NASDAQ:CLDXRead Weiss Ratings Reaffirms Sell (D-) Rating for Celldex Therapeutics (NASDAQ:CLDX) Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened8Krispy Kreme (NASDAQ:DNUT) Shares Up 15.5% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Celcuity (NASDAQ:CELC)MarketBeatNASDAQ:CELCRead Weiss Ratings Reaffirms Sell (D-) Rating for Celcuity (NASDAQ:CELC)2 hours agoCelanese (NYSE:CE) Given Sell (D) Rating at Weiss RatingsMarketBeatNYSE:CERead Celanese (NYSE:CE) Given Sell (D) Rating at Weiss Ratings2 hours agoCECO Environmental (NASDAQ:CECO) Earns Buy (B-) Rating from Weiss RatingsMarketBeatNASDAQ:CECORead CECO Environmental (NASDAQ:CECO) Earns Buy (B-) Rating from Weiss Ratings2 hours agoCCC Intelligent Solutions (NASDAQ:CCCS) Given Sell (D) Rating at Weiss RatingsMarketBeatNASDAQ:CCCSRead CCC Intelligent Solutions (NASDAQ:CCCS) Given Sell (D) Rating at Weiss Ratings2 hours agoCBRE Group (NYSE:CBRE) Receives Buy (B-) Rating from Weiss RatingsMarketBeatNYSE:CBRERead CBRE Group (NYSE:CBRE) Receives Buy (B-) Rating from Weiss Ratings2 hours agoCBIZ (NYSE:CBZ) Cut to "Sell (D+)" at Weiss RatingsMarketBeatNYSE:CBZRead CBIZ (NYSE:CBZ) Cut to "Sell (D+)" at Weiss Ratings2 hours agoChina BAK Battery (NASDAQ:CBAT) Receives Sell (D) Rating from Weiss RatingsMarketBeatNASDAQ:CBATRead China BAK Battery (NASDAQ:CBAT) Receives Sell (D) Rating from Weiss Ratings2 hours agoCB Financial Services (NASDAQ:CBFV) Receives "Buy (B)" Rating from Weiss RatingsMarketBeatNASDAQ:CBFVRead CB Financial Services (NASDAQ:CBFV) Receives "Buy (B)" Rating from Weiss Ratings2 hours agoCayson Acquisition's (CAPN) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CAPNRead Cayson Acquisition's (CAPN) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for CAVA Group (NYSE:CAVA)MarketBeatNYSE:CAVARead Weiss Ratings Reaffirms Hold (C) Rating for CAVA Group (NYSE:CAVA)2 hours agoCathay General Bancorp's (CATY) Buy (B-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CATYRead Cathay General Bancorp's (CATY) Buy (B-) Rating Reaffirmed at Weiss Ratings2 hours agoCatalyst Pharmaceuticals (NASDAQ:CPRX) Earns Hold (C+) Rating from Weiss RatingsMarketBeatNASDAQ:CPRXRead Catalyst Pharmaceuticals (NASDAQ:CPRX) Earns Hold (C+) Rating from Weiss Ratings2 hours agoCatalyst Bancorp's (CLST) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CLSTRead Catalyst Bancorp's (CLST) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C) Rating for Cass Information Systems (NASDAQ:CASS)MarketBeatNASDAQ:CASSRead Weiss Ratings Reiterates Hold (C) Rating for Cass Information Systems (NASDAQ:CASS)2 hours agoWeiss Ratings Reiterates "Buy (B)" Rating for Casey's General Stores (NASDAQ:CASY)MarketBeatNASDAQ:CASYRead Weiss Ratings Reiterates "Buy (B)" Rating for Casey's General Stores (NASDAQ:CASY)2 hours agoWeiss Ratings Reiterates "Sell (D+)" Rating for Casella Waste Systems (NASDAQ:CWST)MarketBeatNASDAQ:CWSTRead Weiss Ratings Reiterates "Sell (D+)" Rating for Casella Waste Systems (NASDAQ:CWST)2 hours agoCartesian Therapeutics (NASDAQ:RNAC) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:RNACRead Cartesian Therapeutics (NASDAQ:RNAC) Earns Sell (D-) Rating from Weiss Ratings2 hours agoCarter Bankshares (NASDAQ:CARE) Upgraded by Weiss Ratings to Buy (B-) RatingMarketBeatNASDAQ:CARERead Carter Bankshares (NASDAQ:CARE) Upgraded by Weiss Ratings to Buy (B-) Rating2 hours agoCarrier Global's (CARR) Buy (B-) Rating Reiterated at Weiss RatingsMarketBeatNYSE:CARRRead Carrier Global's (CARR) Buy (B-) Rating Reiterated at Weiss Ratings2 hours agoCarriage Services (NYSE:CSV) Earns "Buy (B-)" Rating from Weiss RatingsMarketBeatNYSE:CSVRead Carriage Services (NYSE:CSV) Earns "Buy (B-)" Rating from Weiss Ratings2 hours agoCarnival's (CUK) "Hold (C+)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:CUKRead Carnival's (CUK) "Hold (C+)" Rating Reaffirmed at Weiss Ratings2 hours agoCarnival's (CCL) Hold (C+) Rating Reiterated at Weiss RatingsMarketBeatNYSE:CCLRead Carnival's (CCL) Hold (C+) Rating Reiterated at Weiss Ratings2 hours agoCaribou Biosciences' (CRBU) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CRBURead Caribou Biosciences' (CRBU) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoCarGurus (NASDAQ:CARG) Receives Hold (C) Rating from Weiss RatingsMarketBeatNASDAQ:CARGRead CarGurus (NASDAQ:CARG) Receives Hold (C) Rating from Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Nvidia CEO Makes First Ever Tesla AnnouncementFrom Brownstone Research (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025$100 Trillion “AI Metal” Found in American Ghost TownFrom Brownstone Research (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
